Rhodamines < Ribavirin < Ribonuclease H

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 52.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000785 (2020)	Abdo A. Elfiky [Arabie saoudite]	Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
000963 (2018)	François Ferron [France] ; Lorenzo Subissi [France] ; Ana Theresa Silveira De Morais [France] ; Nhung Thi Tuyet Le [France] ; Marion Sevajol [France] ; Laure Gluais [France] ; Etienne Decroly [France] ; Clemens Vonrhein [Royaume-Uni] ; Gérard Bricogne [Royaume-Uni] ; Bruno Canard [France] ; Isabelle Imbert [France]	Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA.
000A62 (2017)	Lu Yu [République populaire de Chine] ; Xiuhai Gan [République populaire de Chine] ; Dagui Zhou [République populaire de Chine] ; Fangcheng He [République populaire de Chine] ; Song Zeng [République populaire de Chine] ; Deyu Hu [République populaire de Chine]	Synthesis and Antiviral Activity of Novel 1,4-Pentadien-3-one Derivatives Containing a 1,3,4-Thiadiazole Moiety.
000A79 (2017)	Kevin W. Graepel [États-Unis] ; Xiaotao Lu [États-Unis] ; James Brett Case [États-Unis] ; Nicole R. Sexton [États-Unis] ; Everett Clinton Smith [États-Unis] ; Mark R. Denison [États-Unis]	Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations.
000D07 (2016)	Yin Mo [Singapour] ; Dale Fisher [Singapour]	A review of treatment modalities for Middle East Respiratory Syndrome.
000D70 (2015)	Mohammed Khalid [Arabie saoudite] ; Fahad Al Rabiah ; Basha Khan ; Abdullah Al Mobeireek ; Taimur S. Butt ; Eid Al Mutairy	Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases.
000F29 (2014)	David S. Hui [Royaume-Uni] ; Ziad A. Memish ; Alimuddin Zumla	Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
001151 (2013)	Darryl Falzarano [États-Unis] ; Emmie De Wit ; Cynthia Martellaro ; Julie Callison ; Vincent J. Munster ; Heinz Feldmann	Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin.
001191 (2013)	Meng Wu [République populaire de Chine] ; Ziwen Wang ; Chuisong Meng ; Kailiang Wang ; Yanna Hu ; Lizhong Wang ; Qingmin Wang	Discovery and SARs of trans-3-aryl acrylic acids and their analogs as novel anti-tobacco mosaic virus (TMV) agents.
001398 (2011)	V N Shchukina ; S Ia Loginova ; S V Borisevich ; V P Bondarev	[Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome].
001399 (2011)	V N Shchukina ; S Ia Loginova ; S V Borisevich ; V P Bondarev	[Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV].
001990 (2008)	Samson S Y. Wong [Hong Kong] ; Kwok-Yung Yuen	The management of coronavirus infections with particular reference to SARS.
001D22 (2007)	Kap-Sun Yeung [États-Unis] ; Nicholas A. Meanwell	Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
001D27 (2007)	Julian W. Tang [République populaire de Chine] ; Ka-Fai To ; Anthony W I. Lo ; Joseph J Y. Sung ; H K Ng ; Paul K S. Chan	Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues.
001D40 (2007)	Dessmon Y H. Tai [Singapour]	Pharmacologic treatment of SARS: current knowledge and recommendations.
001F16 (2006)	Yazdan Yazdanpanah ; Benoît Guéry	[Antiretroviral drugs in severe acute respiratory syndrome].
001F54 (2006)	Chung-Hua Hsu [Taïwan] ; Kung-Chang Hwang ; Chung-Liang Chao ; Steve G N. Chang ; Cheng-Chin Ker ; Lin-Chen Chien ; Mei-Shang Ho ; Jaung-Geng Lin ; Yi-Ming Chen ; Pesus Chou	The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients.
001F73 (2006)	Shao Li [République populaire de Chine] ; Ruiqin Wang ; Yulong Zhang ; Xuegong Zhang ; A Joseph Layon ; Yanda Li ; Mingzhe Chen	Symptom combinations associated with outcome and therapeutic effects in a cohort of cases with SARS.
002144 (2006)	Carla Amici [Italie] ; Antonino Di Caro ; Alessandra Ciucci ; Lucia Chiappa ; Concetta Castilletti ; Vito Martella ; Nicola Decaro ; Canio Buonavoglia ; Maria R. Capobianchi ; M Gabriella Santoro	Indomethacin has a potent antiviral activity against SARS coronavirus.
002206 (2006)	Dale L. Barnard [États-Unis] ; Craig W. Day ; Kevin Bailey ; Matthew Heiner ; Robert Montgomery ; Larry Lauridsen ; Scott Winslow ; Justin Hoopes ; Joseph K-K Li ; Jongdae Lee ; Dennis A. Carson ; Howard B. Cottam ; Robert W. Sidwell	Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
002297 (2006)	Shiro Shigeta [Japon] ; Shuichi Mori ; Toshihiro Yamase ; Norio Yamamoto ; Naoki Yamamoto	Anti-RNA virus activity of polyoxometalates.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Ribavirin" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Ribavirin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Ribavirin
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021